FREEDOM weighs CABG, PCI in patients with diabetes, heart disease

Bypass surgery carries lower risks of death and MI than percutaneous coronary intervention but higher risk of stroke in patients with diabetes who have multivessel disease, according to results of the FREEDOM trial presented at the American Heart Association meeting. "If you were to look solely at death and MI, CABG is clearly superior in this trial," said Dr. Ajay J. Kirtane of the findings. "But the two procedures are clearly different from a patient-oriented perspective, particularly with regards to the invasive nature of the two procedures and the increased stroke risk, especially within 30 days."

View Full Article in:

CardiovascularBusiness.com · TheHeart.org (Montreal) · Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Chief Medical Officer
Meritus
Tempe, AZ